Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I)

Human Immunology

Volumn 60, Issue 1, 1999, Pages 32-40

  Furukawa, Hiroshi ^a,b   Yabe, Toshio ^a   Watanabe, Kaoru ^a   Miyamoto, Ritsuko ^a   Miki, Akinori ^a   Akaza, Tatsuya ^a   Tadokoro, Kenji ^a   Tohma, Shigeto ^b   Inoue, Tetsufumi ^b   Yamamoto, Kazuhiko ^b   Juji, Takeo ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cytotoxicity; HLA; NK cells; NK receptor; Tolerance

Indexed keywords

HLA ANTIGEN CLASS 1; LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BARE LYMPHOCYTE SYNDROME; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0032931296     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00097-4     Document Type: Article

References (26)

1. de la Salle H., Hanau D., Fricker D., Urlacher A., Kelly A., Salamero J., Powis S.H., Donato L., Bausinger H., Laforet M., Jeras M., Spehner D., Bieber T., Falkenrodt A., Cazenave J., Trowsdale J., Tongio M. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science. 265:(5169):1994;237-241.
2. Ljunggren H.G., Karre K. In search of the 'missing self' MHC molecules and NK cell recognition . Immunol Today. 11:(7):1990;237-244.
3. Storkus W.J., Dawson J.R. Target structures involved in natural killing (NK) characteristics, distribution, and candidate molecules . Critical Reviews in Immunology. 10:(5):1991;393-416.
4. Ciccone E., Pende D., Viale O., Than A., Di D.C., Orengo A.M., Biassoni R., Verdiani S., Amoroso A., Moretta A., Moretta L. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2) . J Exp Med. 176:(4):1992;963-971.
5. Colonna M., Borsellino G., Falco M., Ferrara G.B., Strominger J.L. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA. 90:(24):1993;12000-12004.
6. Lanier L.L. Natural killer cells from no receptors to too many . Immunity. 6:(4):1997;371-378.
7. Gumperz J.E., Parham P. The enigma of the natural killer cell. Nature. 378:(6554):1995;245-248.
8. Colonna M. Natural killer cell receptors specific for MHC class I molecules. Current Opinion in Immunology. 8:(1):1996;101-107.
9. Leibson P.J. Signal transduction during natural killer cell activation inside the mind of a killer . Immunity. 6:(6):1997;655-661.
10. Lanier L.L. Follow the leader NK cell receptors for classical and nonclassical MHC class I . Cell. 92:(6):1998;705-707.
11. Houchins J.P., Lanier L.L., Niemi E.C., Phillips J.H., Ryan J.C. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol. 158:(8):1997;3603-3609.
12. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD9 4/NKG2A, B and C. Nature. 391:(6669):1998;795-799.
13. Touraine J.L. The bare-lymphocyte syndrome report on the registry . Lancet. 1:(8215):1981;319-321.
14. Teisserenc H., Schmitt W., Blake N., Dunbar R., Gadola S., Gross W.L., Exley A., Cerundolo V. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. Immunol Lett. 57:(1-3):1997;183-187.
15. Zimmer J., Donato L., Hanau D., Cazenave J.P., Tongio M.M., Moretta A., de la Salle H. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med. 187:(1):1998;117-122.
16. Hoglund P., Ohlen C., Carbone E., Franksson L., Ljunggren H.G., Latour A., Koller B., Karre K. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice . Proc Natl Acad Sci USA. 88:(22):1991;10332-10336.
17. Ljunggren H.G., Van Kaer L., Ploegh H.L., Tonegawa S. Altered natural killer cell repertoire in Tap-1 mutant mice. Proc Natl Acad Sci USA. 91:(14):1994;6520-6524.
18. Salcedo M., Anderson M., Lemieux S., Van Kaer L., Chambers B.J., Ljunggren H.G. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur J Immunol. 28:(4):1998;1315-1321.
19. Maeda H., Hirata R., Chen R.F., Suzaki H., Kudoh S., Tohyama H. Defective expression of HLA class I antigens a case of the bare lymphocyte without immunodeficiency . Immunogenetics. 21:(6):1985;549-558.
20. Haridas V., Saxena R.K. Correlation of class I MHC antigen levels on some human tumor cell lines with susceptibility to LAK cells and performance in cold target inhibition assays. Cellular Immunol. 161:(2):1995;256-261.
21. Perez-Villar J.J., Melero I., Navarro F., Carretero M., Bellon T., Llano M., Colonna M., Geraghty D.E., Lopez-Botet M. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol. 158:(12):1997;5736-5743.
22. Furukawa H., Yabe T., Watanabe K., Miyamoto R., Akaza T., Tadokoro K., Tohma S., Inoue T., Yamamoto K., Juji T. An alternatively spliced form of the human CD94 gene. Immunogenetics. 48:(1):1998;87-88.
23. Ciccone E. Negative selection for natural killer cells? Immunology Today. 16:(11):1995;546-547.
24. Saxena R.K. Ontogeny of inhibitory receptors for MHC molecules on NK cells. Immunol Today. 18:(3):1997;146.
25. DiSanto J.P. Cytokines shared receptors, distinct functions . Curr Biol. 7:(7):1997;R424-R426.
26. Ihle J.N. Cytokine receptor signalling. Nature. 377:(6550):1995;591-594.